España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Marker Therapeutics
MRKR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Marker Therapeutics (MRKR) Forecast
News
Earnings
Marker Therapeutics (MRKR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Marker Therapeutics (NASDAQ:MRKR) Stock
Marker Therapeutics Stock (NASDAQ: MRKR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 19, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Marker Therapeutics shares are trading lower....
Benzinga Newsdesk
Marker Therapeutics Reports Results From Phas...
Benzinga Newsdesk
Marker Therapeutics Secures $16.1M In Private...
Benzinga Newsdesk
Tuesday, December 17, 2024
Marker Therapeutics shares are trading higher...
Benzinga Newsdesk
Marker Therapeutics Wins $9.5M Grant to Study...
Benzinga Newsdesk
Thursday, December 05, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, November 27, 2024
Marker Therapeutics Sales Agreement Prospectu...
Benzinga Newsdesk
Marker Therapeutics Files For Mixed Shelf Of ...
Benzinga Newsdesk
Friday, November 15, 2024
Marker Therapeutics shares are trading lower....
Benzinga Newsdesk
Thursday, November 14, 2024
Marker Therapeutics Q3 2024 GAAP EPS $(0.26) ...
Benzinga Newsdesk
Wednesday, August 14, 2024
Marker Therapeutics Q2 2024 GAAP EPS $(0.25) ...
Benzinga Newsdesk
Monday, August 12, 2024
NIH Awards Marker Therapeutics $2M for Clinic...
Benzinga Newsdesk
Wednesday, June 05, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Wednesday, May 15, 2024
Marker Therapeutics Q1 EPS $(0.27) Up From $(...
Benzinga Newsdesk
Tuesday, April 30, 2024
Ladenburg Thalmann Initiates Coverage On Mark...
Benzinga Newsdesk
Monday, March 25, 2024
Marker Therapeutics Reports 2023 Net Loss Of ...
Benzinga Newsdesk
Monday, January 22, 2024
Marker Therapeutics Receives Approval from Un...
Benzinga Newsdesk
Monday, January 08, 2024
Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization
Vandana Singh
Marker Therapeutics Says 'MultiTAA-specific T...
Benzinga Newsdesk
Marker Therapeutics Says 'Strategic prioritiz...
Benzinga Newsdesk
Marker Therapeutics Announces Clinical Progra...
Benzinga Newsdesk
Friday, December 29, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, December 11, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Marker Therapeutics shares are trading higher...
Benzinga Newsdesk
Marker Therapeutics Announces Sustained Compl...
Benzinga Newsdesk
Friday, November 10, 2023
Marker Therapeutics Q3 EPS $(0.34) Up From $(...
Benzinga Newsdesk
Monday, September 11, 2023
Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?
Vandana Singh
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Marker Therapeutics Announced The Preliminary...
Benzinga Newsdesk
Tuesday, August 15, 2023
Marker Therapeutics shares are trading higher...
Benzinga Newsdesk
Monday, August 14, 2023
Marker Therapeutics Q2 EPS $0.29 Up From $(1....
Benzinga Newsdesk
Monday, August 07, 2023
Marker Therapeutics Announced Non-clinical Da...
Benzinga Newsdesk
Monday, July 31, 2023
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
Lisa Levin
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, July 28, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Monday, July 24, 2023
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Tuesday, July 18, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Tuesday, July 11, 2023
What's Going On With Marker Therapeutics (MRKR) Stock
Henry Khederian
Monday, July 10, 2023
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why Marker Therapeutics (MRKR) Stock Is Trading Sharply Higher
Henry Khederian
Marker Therapeutics shares are trading higher...
Benzinga Newsdesk
Marker Therapeutics Says European Medicines A...
Benzinga Newsdesk
Tuesday, June 13, 2023
Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Monday, June 12, 2023
Nasdaq Gains 1%; US Budget Deficit Widens In May
Lisa Levin
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Crude Oil Drops Sharply; Chinook Therapeutics Shares Spike Higher
Lisa Levin
Marker Therapeutics shares are trading higher...
Benzinga Newsdesk
Marker Therapeutics Announces First Lymphoma ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch